(Q41526034)

2 October 2017

1 reference

title

Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease (English)

1 reference

2 October 2017

1 reference

1 reference

2

Blaser MJ

1 reference

2 October 2017

Peek RM Jr

1

1 reference

PubMed ID

9217571

2 October 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

American Journal of Medicine

2 October 2017

1 reference

2 October 2017

102

1 reference

2 October 2017

2

1 reference

2 October 2017

200-207

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

The Epidemiology of Helicobacter pylori Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection and the risk for duodenal and gastric ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori: its role in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection and gastric lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori and gastric acid: biological and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Characterization of the Helicobacter pylori urease and purification of its subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Bacterial adhesion and Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mannose-resistant Haemagglutination by Campylobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pylori antibodies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

A sensitive and specific serologic test for detection of Campylobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Opsonic activity of specific human IgG against Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Susceptibility of Helicobacter pylori to the bactericidal activity of human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pyloridis, gastritis, and peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Paf-acether synthesis by Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mechanisms involved in Helicobacter pylori-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Interferon-gamma and tumour necrosis factor production in patients with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori and peptic ulceration: histopathological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Cytotoxic activity in broth-culture filtrates of Campylobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Amino terminus and the first four membrane-spanning segments of the Arabidopsis K+ channel KAT1 confer inward-rectification property of plant-animal chimeric channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Pharmacological aspects of acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Helicobacter pylori infection: physiopathologic implication of N alpha-methyl histamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

Campylobacter pylori virulence factors in gnotobiotic piglets

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900273-2

7 January 2021

10.1016/S0002-9343(96)00273-2

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9217571